Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00582_DB00813_nanopub.RATwRC4KtqnuJtu6tRilAZ8r2PPyBiAAPnjICR_J9X-zg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00582_DB00813 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00582_DB00813 label "DDI between Voriconazole and Fentanyl - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of fentanyl by decreasing its metabolism. Adverse effects include life-threatening respiratory depression. Monitor for changes in the therapeutic and adverse effects of fentanyl if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00582_DB00813]" assertion.
- drugbank_resource:DB00582_DB00813 identifier "drugbank_resource:DB00582_DB00813" assertion.
- drugbank_resource:DB00582_DB00813 title "DDI between Voriconazole and Fentanyl - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of fentanyl by decreasing its metabolism. Adverse effects include life-threatening respiratory depression. Monitor for changes in the therapeutic and adverse effects of fentanyl if voriconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00813 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB00813 assertion.
- drugbank:DB00582 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB00813 assertion.